Abbott’s $21 Billion Exact Sciences Deal Fills Void Of Lost Covid Test Sales

Abbott Laboratories $21 billion deal to acquire cancer test maker Exact Sciences could bolster the company’s diagnostic division that has lost sales from tests for the coronavirus. (Stacey Wescott/Chicago Tribune/Tribune News Service via Getty…